Anti-Human ACVR2A & ACVR2B Recombinant Antibody_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human ACVR2A & ACVR2B Recombinant Antibody

Anti-Human ACVR2A & ACVR2B Recombinant Antibody

产品编号

YR1301

别名

科研级 Bimagrumab ( 比玛卢单抗 ), Anti-ACVR2A & ACVR2B Recombinant Antibody, Research Grade Bimagrumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Bimagrumab ( 比玛卢单抗 ), Anti-ACVR2A & ACVR2B Recombinant Antibody, Research Grade Bimagrumab
Catalog Number	YR1301
Molecular Name	Bimagrumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Lambda
Formulation	PBS, pH7.5
Background	Bimagrumab (BYM338) is a human monoclonal antibody developed by Novartis to treat pathological muscle loss and weakness. On August 20, 2013, it was announced that bimagrumab had received a breakthrough therapy designation for sporadic inclusion body myositis (sIBM) by the US Food and Drug Administration.
CAS Number	1356922-05-8
Application	FCM, IP, ELISA, Neut, FuncS, IF, ICC, MRI
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	ACVR2A & ACVR2B[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0

可以介绍下你们的产品么

你们是怎么收费的呢

现在有优惠活动吗

请您留言

感谢您的关注，当前客服人员不在线，请填写一下您的信息，我们会尽快和您联系。

提交